.svg)
.svg)
.svg)
.svg)
.svg)
Turmeric
.svg)
.svg)
Turmeric (Curcuma longa), the golden root of Ayurvedic fame, is a potent anti-inflammatory and antioxidant botanical. Its active compound, curcumin, helps reduce joint discomfort, support digestion, and promote cellular repair—making it ideal for daily recovery and longevity.
With powerful support for brain, heart, and immune health, Turmeric helps your body stay resilient under stress and age-related wear. Organica’s formula includes black pepper extract for optimal absorption and bioavailability.
Supplement Facts
Other Ingredients: Vegetable Cellulose (Veggie Capsule)
Take 1–2 capsules daily with food. Pair with healthy fats for enhanced absorption.
Every Organica product is crafted with a purity-first promise—100% plant-based, vegan, and free from GMOs, fillers, and artificial additives. Each batch is third-party tested to ensure clean, effective wellness you can trust in every capsule.
.svg)
.svg)
.svg)
.svg)
.svg)
.svg)
The Golden Root for Daily Renewal
Promotes Joint & Bone Strength
Provides key minerals and anti-inflammatory support to nourish bone density and maintain joint flexibility over time.
Reduces Inflammation Naturally
Helps regulate internal systems and supports a calm, steady response to everyday physical demands.
Strengthens Immune Defense
Helps fortify your body’s frontline defenses against seasonal threats and environmental stressors.
The Golden Root for Daily Renewal
Strengthens Immune Defense
Helps fortify your body’s frontline defenses against seasonal threats and environmental stressors.
Promotes Joint & Bone Strength
Provides key minerals and anti-inflammatory support to nourish bone density and maintain joint flexibility over time.
Reduces Inflammation Naturally
Helps regulate internal systems and supports a calm, steady response to everyday physical demands.
Main Ingredients
Turmeric
Organica’s Turmeric capsules deliver a clinically validated, high-bioavailability curcumin extract shown in human trials to support immunity, reduce inflammation, and provide robust antioxidant defense.
.svg)
Turmeric
.svg){kind=small}
Origin: A culinary rhizome long used in Ayurveda. Modern trials employ curcumin-standardized extracts (often with bioavailability enhancers like piperine or novel dispersions).
How it works
Curcumin down-regulates NF-κB/COX-2 inflammatory signaling and activates Nrf2/HO-1 antioxidant defenses—mechanisms consistent with lower CRP/TNF-α/IL-6, improved joint function (WOMAC/KOOS), and immune support in human RCTs. (BPS Publications)
Top 5 Clinically Supported Benefits
1) Joint comfort & function (knee OA)
DB-RCTs and a 2022 meta-analysis of 29 RCTs (n=2,396) report significant pain and function improvements in arthritis; effects were comparable to NSAIDs with fewer adverse events. An 8-week DB-RCT in knee OA (n=101) using 500 mg BID curcumin improved KOOS pain, 6-min walk, and timed up-and-go vs placebo; pain-medication use fell (37% vs 13%). Study chips: Dose 500–1000 mg/day • Duration 8–12 wk • Endpoints WOMAC/KOOS, VAS, performance tests • Design DB-RCTs + meta-analysis. (Frontiers, MDPI)
2) Systemic inflammation markers ↓ (CRP, TNF-α, IL-6)
A DB-RCT in metabolic syndrome (n=117) using 1 g/day curcuminoids + piperine for 8 weeks reduced hs-CRP and oxidative stress; its embedded meta-analysis of RCTs confirmed CRP lowering. Multiple updated meta-analyses likewise show significant CRP/hs-CRP reductions. Study chips: Dose 500–1000 mg/day • Duration 8–12 wk • Endpoints CRP/hs-CRP, TNF-α, IL-6 • Design DB-RCT + meta-analyses. (Europe PMC, ScienceDirect)
3) Immune support (common cold symptoms)
In healthy adults (DB-RCT, n=99), 12 weeks of highly bioavailable curcumin (150 mg/day) shortened common-cold symptom duration and modulated immune/inflammatory readouts vs placebo. Study chips: Dose 150 mg/day (bioavailable) • Duration 12 wk • Endpoints symptom days/severity, immune markers • Design DB-RCT. (Taylor & Francis Online, Examine)
4) Exercise recovery & soreness (DOMS)
Across controlled human trials—including a double-blind cross-over and a DB-RCT with bioavailable curcumin—supplementation reduced muscle soreness and showed lower CK after eccentric exercise vs placebo. Study chips: Dose ~1.5–5 g/day (legacy) or bioavailable forms at lower mg • Duration peri-/post-exercise (2–7 days) • Endpoints DOMS ratings, CK • Design DB cross-over + DB-RCT. (SpringerLink, Europe PMC)
5) Quality & safety signals
Across arthritis RCTs, curcumin showed favorable tolerance and NSAID-like efficacy without increased adverse events, supporting use in joint-health stacks when monitored appropriately. Study chips: Dose 120–1500 mg/day • Duration 4–36 wk • Endpoints AE rates, discontinuations • Design Meta-analysis + RCTs. (Frontiers)
Summary
Human double-blind, placebo-controlled trials—plus large meta-analyses—indicate that standardized curcumin extracts can improve knee-OA pain/function, lower CRP and key cytokines, support immune resilience (shorter common-cold symptoms), and speed exercise recovery. Most effective protocols use bioavailability-enhanced curcumin at 150–1000 mg/day for 8–12 weeks, or peri-exercise for DOMS, with endpoints like WOMAC/KOOS, VAS, 6-min walk, CRP/hs-CRP, TNF-α/IL-6, symptom days, CK. To mirror trials, choose clearly standardized extract(s) with third-party COA, then use consistently for the studied window. (Frontiers, MDPI, Europe PMC, Taylor & Francis Online)
Why choose Organica to reach those outcomes
- Clinically aligned dosing (easy 150–1000 mg/day targeting; bioavailability-enhanced extract)
- Root-cause formulation: curcumin standardized; optional piperine or dispersion tech (per RCTs)
- Third-party COA (identity, curcuminoids by HPLC/UPLC, heavy metals, microbes, pesticides, solvents)
- cGMP small-batch, clean excipients; vegan capsules
References (MIT style, with links)
- Zeng, Liuting, Tiejun Yang, Kailin Yang, et al. “Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Frontiers in Immunology 13 (2022): 891822. https://doi.org/10.3389/fimmu.2022.891822. (Frontiers)
- Lopresti, Adrian L., Stephen J. Smith, Shavon Jackson-Michel, and Timothy Fairchild. “An Investigation into the Effects of a Curcumin Extract (Curcugen®) on Osteoarthritis Pain of the Knee: A Randomised, Double-Blind, Placebo-Controlled Study.” Nutrients 14, no. 1 (2022): 41. https://doi.org/10.3390/nu14010041. (MDPI)
- Panahi, Y., M. S. Hosseini, N. Khalili, E. Naimi, M. Majeed, and A. Sahebkar. “Antioxidant and Anti-inflammatory Effects of Curcuminoid-Piperine Combination in Subjects with Metabolic Syndrome: A Randomized Controlled Trial and an Updated Meta-analysis.” Clinical Nutrition 34, no. 6 (2015): 1101–1108. https://www.clinicalnutritionjournal.com/article/S0261-5614(15)00002-3/fulltext. (Clinical Nutrition Journal)
- Kuwabara, Y., A. Hirose, H. Lee, T. Kakinuma, A. Baba, and T. Takara. “Effects of Highly Bioavailable Curcumin Supplementation on Common Cold Symptoms and Immune and Inflammatory Functions in Healthy Japanese Subjects: A Randomized Controlled Study.” Journal of Dietary Supplements (2023). https://doi.org/10.1080/19390211.2023.2185723. (Taylor & Francis Online)
- Rowlands, D. S., R. Fazakerly, and J. Kellett. “Curcumin Supplementation Likely Attenuates Delayed Onset Muscle Soreness (DOMS).” European Journal of Applied Physiology 115 (2015): 1769–1777. https://doi.org/10.1007/s00421-015-3152-6. (SpringerLink)
Regulatory note: These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. If you use NSAIDs/anticoagulants, are pregnant/breastfeeding, or have gallbladder issues, consult a clinician before use.
Turmeric
Organica’s Turmeric capsules deliver a clinically validated, high-bioavailability curcumin extract shown in human trials to support immunity, reduce inflammation, and provide robust antioxidant defense.
Turmeric
Origin: A culinary rhizome long used in Ayurveda. Modern trials employ curcumin-standardized extracts (often with bioavailability enhancers like piperine or novel dispersions).
How it works
Curcumin down-regulates NF-κB/COX-2 inflammatory signaling and activates Nrf2/HO-1 antioxidant defenses—mechanisms consistent with lower CRP/TNF-α/IL-6, improved joint function (WOMAC/KOOS), and immune support in human RCTs. (BPS Publications)
Top 5 Clinically Supported Benefits
1) Joint comfort & function (knee OA)
DB-RCTs and a 2022 meta-analysis of 29 RCTs (n=2,396) report significant pain and function improvements in arthritis; effects were comparable to NSAIDs with fewer adverse events. An 8-week DB-RCT in knee OA (n=101) using 500 mg BID curcumin improved KOOS pain, 6-min walk, and timed up-and-go vs placebo; pain-medication use fell (37% vs 13%). Study chips: Dose 500–1000 mg/day • Duration 8–12 wk • Endpoints WOMAC/KOOS, VAS, performance tests • Design DB-RCTs + meta-analysis. (Frontiers, MDPI)
2) Systemic inflammation markers ↓ (CRP, TNF-α, IL-6)
A DB-RCT in metabolic syndrome (n=117) using 1 g/day curcuminoids + piperine for 8 weeks reduced hs-CRP and oxidative stress; its embedded meta-analysis of RCTs confirmed CRP lowering. Multiple updated meta-analyses likewise show significant CRP/hs-CRP reductions. Study chips: Dose 500–1000 mg/day • Duration 8–12 wk • Endpoints CRP/hs-CRP, TNF-α, IL-6 • Design DB-RCT + meta-analyses. (Europe PMC, ScienceDirect)
3) Immune support (common cold symptoms)
In healthy adults (DB-RCT, n=99), 12 weeks of highly bioavailable curcumin (150 mg/day) shortened common-cold symptom duration and modulated immune/inflammatory readouts vs placebo. Study chips: Dose 150 mg/day (bioavailable) • Duration 12 wk • Endpoints symptom days/severity, immune markers • Design DB-RCT. (Taylor & Francis Online, Examine)
4) Exercise recovery & soreness (DOMS)
Across controlled human trials—including a double-blind cross-over and a DB-RCT with bioavailable curcumin—supplementation reduced muscle soreness and showed lower CK after eccentric exercise vs placebo. Study chips: Dose ~1.5–5 g/day (legacy) or bioavailable forms at lower mg • Duration peri-/post-exercise (2–7 days) • Endpoints DOMS ratings, CK • Design DB cross-over + DB-RCT. (SpringerLink, Europe PMC)
5) Quality & safety signals
Across arthritis RCTs, curcumin showed favorable tolerance and NSAID-like efficacy without increased adverse events, supporting use in joint-health stacks when monitored appropriately. Study chips: Dose 120–1500 mg/day • Duration 4–36 wk • Endpoints AE rates, discontinuations • Design Meta-analysis + RCTs. (Frontiers)
Summary
Human double-blind, placebo-controlled trials—plus large meta-analyses—indicate that standardized curcumin extracts can improve knee-OA pain/function, lower CRP and key cytokines, support immune resilience (shorter common-cold symptoms), and speed exercise recovery. Most effective protocols use bioavailability-enhanced curcumin at 150–1000 mg/day for 8–12 weeks, or peri-exercise for DOMS, with endpoints like WOMAC/KOOS, VAS, 6-min walk, CRP/hs-CRP, TNF-α/IL-6, symptom days, CK. To mirror trials, choose clearly standardized extract(s) with third-party COA, then use consistently for the studied window. (Frontiers, MDPI, Europe PMC, Taylor & Francis Online)
Why choose Organica to reach those outcomes
- Clinically aligned dosing (easy 150–1000 mg/day targeting; bioavailability-enhanced extract)
- Root-cause formulation: curcumin standardized; optional piperine or dispersion tech (per RCTs)
- Third-party COA (identity, curcuminoids by HPLC/UPLC, heavy metals, microbes, pesticides, solvents)
- cGMP small-batch, clean excipients; vegan capsules
References (MIT style, with links)
- Zeng, Liuting, Tiejun Yang, Kailin Yang, et al. “Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Frontiers in Immunology 13 (2022): 891822. https://doi.org/10.3389/fimmu.2022.891822. (Frontiers)
- Lopresti, Adrian L., Stephen J. Smith, Shavon Jackson-Michel, and Timothy Fairchild. “An Investigation into the Effects of a Curcumin Extract (Curcugen®) on Osteoarthritis Pain of the Knee: A Randomised, Double-Blind, Placebo-Controlled Study.” Nutrients 14, no. 1 (2022): 41. https://doi.org/10.3390/nu14010041. (MDPI)
- Panahi, Y., M. S. Hosseini, N. Khalili, E. Naimi, M. Majeed, and A. Sahebkar. “Antioxidant and Anti-inflammatory Effects of Curcuminoid-Piperine Combination in Subjects with Metabolic Syndrome: A Randomized Controlled Trial and an Updated Meta-analysis.” Clinical Nutrition 34, no. 6 (2015): 1101–1108. https://www.clinicalnutritionjournal.com/article/S0261-5614(15)00002-3/fulltext. (Clinical Nutrition Journal)
- Kuwabara, Y., A. Hirose, H. Lee, T. Kakinuma, A. Baba, and T. Takara. “Effects of Highly Bioavailable Curcumin Supplementation on Common Cold Symptoms and Immune and Inflammatory Functions in Healthy Japanese Subjects: A Randomized Controlled Study.” Journal of Dietary Supplements (2023). https://doi.org/10.1080/19390211.2023.2185723. (Taylor & Francis Online)
- Rowlands, D. S., R. Fazakerly, and J. Kellett. “Curcumin Supplementation Likely Attenuates Delayed Onset Muscle Soreness (DOMS).” European Journal of Applied Physiology 115 (2015): 1769–1777. https://doi.org/10.1007/s00421-015-3152-6. (SpringerLink)
Regulatory note: These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. If you use NSAIDs/anticoagulants, are pregnant/breastfeeding, or have gallbladder issues, consult a clinician before use.
Turmeric
Organica’s Turmeric capsules deliver a clinically validated, high-bioavailability curcumin extract shown in human trials to support immunity, reduce inflammation, and provide robust antioxidant defense.
Turmeric
Origin: A culinary rhizome long used in Ayurveda. Modern trials employ curcumin-standardized extracts (often with bioavailability enhancers like piperine or novel dispersions).
How it works
Curcumin down-regulates NF-κB/COX-2 inflammatory signaling and activates Nrf2/HO-1 antioxidant defenses—mechanisms consistent with lower CRP/TNF-α/IL-6, improved joint function (WOMAC/KOOS), and immune support in human RCTs. (BPS Publications)
Top 5 Clinically Supported Benefits
1) Joint comfort & function (knee OA)
DB-RCTs and a 2022 meta-analysis of 29 RCTs (n=2,396) report significant pain and function improvements in arthritis; effects were comparable to NSAIDs with fewer adverse events. An 8-week DB-RCT in knee OA (n=101) using 500 mg BID curcumin improved KOOS pain, 6-min walk, and timed up-and-go vs placebo; pain-medication use fell (37% vs 13%). Study chips: Dose 500–1000 mg/day • Duration 8–12 wk • Endpoints WOMAC/KOOS, VAS, performance tests • Design DB-RCTs + meta-analysis. (Frontiers, MDPI)
2) Systemic inflammation markers ↓ (CRP, TNF-α, IL-6)
A DB-RCT in metabolic syndrome (n=117) using 1 g/day curcuminoids + piperine for 8 weeks reduced hs-CRP and oxidative stress; its embedded meta-analysis of RCTs confirmed CRP lowering. Multiple updated meta-analyses likewise show significant CRP/hs-CRP reductions. Study chips: Dose 500–1000 mg/day • Duration 8–12 wk • Endpoints CRP/hs-CRP, TNF-α, IL-6 • Design DB-RCT + meta-analyses. (Europe PMC, ScienceDirect)
3) Immune support (common cold symptoms)
In healthy adults (DB-RCT, n=99), 12 weeks of highly bioavailable curcumin (150 mg/day) shortened common-cold symptom duration and modulated immune/inflammatory readouts vs placebo. Study chips: Dose 150 mg/day (bioavailable) • Duration 12 wk • Endpoints symptom days/severity, immune markers • Design DB-RCT. (Taylor & Francis Online, Examine)
4) Exercise recovery & soreness (DOMS)
Across controlled human trials—including a double-blind cross-over and a DB-RCT with bioavailable curcumin—supplementation reduced muscle soreness and showed lower CK after eccentric exercise vs placebo. Study chips: Dose ~1.5–5 g/day (legacy) or bioavailable forms at lower mg • Duration peri-/post-exercise (2–7 days) • Endpoints DOMS ratings, CK • Design DB cross-over + DB-RCT. (SpringerLink, Europe PMC)
5) Quality & safety signals
Across arthritis RCTs, curcumin showed favorable tolerance and NSAID-like efficacy without increased adverse events, supporting use in joint-health stacks when monitored appropriately. Study chips: Dose 120–1500 mg/day • Duration 4–36 wk • Endpoints AE rates, discontinuations • Design Meta-analysis + RCTs. (Frontiers)
Summary
Human double-blind, placebo-controlled trials—plus large meta-analyses—indicate that standardized curcumin extracts can improve knee-OA pain/function, lower CRP and key cytokines, support immune resilience (shorter common-cold symptoms), and speed exercise recovery. Most effective protocols use bioavailability-enhanced curcumin at 150–1000 mg/day for 8–12 weeks, or peri-exercise for DOMS, with endpoints like WOMAC/KOOS, VAS, 6-min walk, CRP/hs-CRP, TNF-α/IL-6, symptom days, CK. To mirror trials, choose clearly standardized extract(s) with third-party COA, then use consistently for the studied window. (Frontiers, MDPI, Europe PMC, Taylor & Francis Online)
Why choose Organica to reach those outcomes
- Clinically aligned dosing (easy 150–1000 mg/day targeting; bioavailability-enhanced extract)
- Root-cause formulation: curcumin standardized; optional piperine or dispersion tech (per RCTs)
- Third-party COA (identity, curcuminoids by HPLC/UPLC, heavy metals, microbes, pesticides, solvents)
- cGMP small-batch, clean excipients; vegan capsules
References (MIT style, with links)
- Zeng, Liuting, Tiejun Yang, Kailin Yang, et al. “Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Frontiers in Immunology 13 (2022): 891822. https://doi.org/10.3389/fimmu.2022.891822. (Frontiers)
- Lopresti, Adrian L., Stephen J. Smith, Shavon Jackson-Michel, and Timothy Fairchild. “An Investigation into the Effects of a Curcumin Extract (Curcugen®) on Osteoarthritis Pain of the Knee: A Randomised, Double-Blind, Placebo-Controlled Study.” Nutrients 14, no. 1 (2022): 41. https://doi.org/10.3390/nu14010041. (MDPI)
- Panahi, Y., M. S. Hosseini, N. Khalili, E. Naimi, M. Majeed, and A. Sahebkar. “Antioxidant and Anti-inflammatory Effects of Curcuminoid-Piperine Combination in Subjects with Metabolic Syndrome: A Randomized Controlled Trial and an Updated Meta-analysis.” Clinical Nutrition 34, no. 6 (2015): 1101–1108. https://www.clinicalnutritionjournal.com/article/S0261-5614(15)00002-3/fulltext. (Clinical Nutrition Journal)
- Kuwabara, Y., A. Hirose, H. Lee, T. Kakinuma, A. Baba, and T. Takara. “Effects of Highly Bioavailable Curcumin Supplementation on Common Cold Symptoms and Immune and Inflammatory Functions in Healthy Japanese Subjects: A Randomized Controlled Study.” Journal of Dietary Supplements (2023). https://doi.org/10.1080/19390211.2023.2185723. (Taylor & Francis Online)
- Rowlands, D. S., R. Fazakerly, and J. Kellett. “Curcumin Supplementation Likely Attenuates Delayed Onset Muscle Soreness (DOMS).” European Journal of Applied Physiology 115 (2015): 1769–1777. https://doi.org/10.1007/s00421-015-3152-6. (SpringerLink)
Regulatory note: These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. If you use NSAIDs/anticoagulants, are pregnant/breastfeeding, or have gallbladder issues, consult a clinician before use.
Turmeric
Organica’s Turmeric capsules deliver a clinically validated, high-bioavailability curcumin extract shown in human trials to support immunity, reduce inflammation, and provide robust antioxidant defense.
Turmeric
Origin: A culinary rhizome long used in Ayurveda. Modern trials employ curcumin-standardized extracts (often with bioavailability enhancers like piperine or novel dispersions).
How it works
Curcumin down-regulates NF-κB/COX-2 inflammatory signaling and activates Nrf2/HO-1 antioxidant defenses—mechanisms consistent with lower CRP/TNF-α/IL-6, improved joint function (WOMAC/KOOS), and immune support in human RCTs. (BPS Publications)
Top 5 Clinically Supported Benefits
1) Joint comfort & function (knee OA)
DB-RCTs and a 2022 meta-analysis of 29 RCTs (n=2,396) report significant pain and function improvements in arthritis; effects were comparable to NSAIDs with fewer adverse events. An 8-week DB-RCT in knee OA (n=101) using 500 mg BID curcumin improved KOOS pain, 6-min walk, and timed up-and-go vs placebo; pain-medication use fell (37% vs 13%). Study chips: Dose 500–1000 mg/day • Duration 8–12 wk • Endpoints WOMAC/KOOS, VAS, performance tests • Design DB-RCTs + meta-analysis. (Frontiers, MDPI)
2) Systemic inflammation markers ↓ (CRP, TNF-α, IL-6)
A DB-RCT in metabolic syndrome (n=117) using 1 g/day curcuminoids + piperine for 8 weeks reduced hs-CRP and oxidative stress; its embedded meta-analysis of RCTs confirmed CRP lowering. Multiple updated meta-analyses likewise show significant CRP/hs-CRP reductions. Study chips: Dose 500–1000 mg/day • Duration 8–12 wk • Endpoints CRP/hs-CRP, TNF-α, IL-6 • Design DB-RCT + meta-analyses. (Europe PMC, ScienceDirect)
3) Immune support (common cold symptoms)
In healthy adults (DB-RCT, n=99), 12 weeks of highly bioavailable curcumin (150 mg/day) shortened common-cold symptom duration and modulated immune/inflammatory readouts vs placebo. Study chips: Dose 150 mg/day (bioavailable) • Duration 12 wk • Endpoints symptom days/severity, immune markers • Design DB-RCT. (Taylor & Francis Online, Examine)
4) Exercise recovery & soreness (DOMS)
Across controlled human trials—including a double-blind cross-over and a DB-RCT with bioavailable curcumin—supplementation reduced muscle soreness and showed lower CK after eccentric exercise vs placebo. Study chips: Dose ~1.5–5 g/day (legacy) or bioavailable forms at lower mg • Duration peri-/post-exercise (2–7 days) • Endpoints DOMS ratings, CK • Design DB cross-over + DB-RCT. (SpringerLink, Europe PMC)
5) Quality & safety signals
Across arthritis RCTs, curcumin showed favorable tolerance and NSAID-like efficacy without increased adverse events, supporting use in joint-health stacks when monitored appropriately. Study chips: Dose 120–1500 mg/day • Duration 4–36 wk • Endpoints AE rates, discontinuations • Design Meta-analysis + RCTs. (Frontiers)
Summary
Human double-blind, placebo-controlled trials—plus large meta-analyses—indicate that standardized curcumin extracts can improve knee-OA pain/function, lower CRP and key cytokines, support immune resilience (shorter common-cold symptoms), and speed exercise recovery. Most effective protocols use bioavailability-enhanced curcumin at 150–1000 mg/day for 8–12 weeks, or peri-exercise for DOMS, with endpoints like WOMAC/KOOS, VAS, 6-min walk, CRP/hs-CRP, TNF-α/IL-6, symptom days, CK. To mirror trials, choose clearly standardized extract(s) with third-party COA, then use consistently for the studied window. (Frontiers, MDPI, Europe PMC, Taylor & Francis Online)
Why choose Organica to reach those outcomes
- Clinically aligned dosing (easy 150–1000 mg/day targeting; bioavailability-enhanced extract)
- Root-cause formulation: curcumin standardized; optional piperine or dispersion tech (per RCTs)
- Third-party COA (identity, curcuminoids by HPLC/UPLC, heavy metals, microbes, pesticides, solvents)
- cGMP small-batch, clean excipients; vegan capsules
References (MIT style, with links)
- Zeng, Liuting, Tiejun Yang, Kailin Yang, et al. “Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Frontiers in Immunology 13 (2022): 891822. https://doi.org/10.3389/fimmu.2022.891822. (Frontiers)
- Lopresti, Adrian L., Stephen J. Smith, Shavon Jackson-Michel, and Timothy Fairchild. “An Investigation into the Effects of a Curcumin Extract (Curcugen®) on Osteoarthritis Pain of the Knee: A Randomised, Double-Blind, Placebo-Controlled Study.” Nutrients 14, no. 1 (2022): 41. https://doi.org/10.3390/nu14010041. (MDPI)
- Panahi, Y., M. S. Hosseini, N. Khalili, E. Naimi, M. Majeed, and A. Sahebkar. “Antioxidant and Anti-inflammatory Effects of Curcuminoid-Piperine Combination in Subjects with Metabolic Syndrome: A Randomized Controlled Trial and an Updated Meta-analysis.” Clinical Nutrition 34, no. 6 (2015): 1101–1108. https://www.clinicalnutritionjournal.com/article/S0261-5614(15)00002-3/fulltext. (Clinical Nutrition Journal)
- Kuwabara, Y., A. Hirose, H. Lee, T. Kakinuma, A. Baba, and T. Takara. “Effects of Highly Bioavailable Curcumin Supplementation on Common Cold Symptoms and Immune and Inflammatory Functions in Healthy Japanese Subjects: A Randomized Controlled Study.” Journal of Dietary Supplements (2023). https://doi.org/10.1080/19390211.2023.2185723. (Taylor & Francis Online)
- Rowlands, D. S., R. Fazakerly, and J. Kellett. “Curcumin Supplementation Likely Attenuates Delayed Onset Muscle Soreness (DOMS).” European Journal of Applied Physiology 115 (2015): 1769–1777. https://doi.org/10.1007/s00421-015-3152-6. (SpringerLink)
Regulatory note: These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. If you use NSAIDs/anticoagulants, are pregnant/breastfeeding, or have gallbladder issues, consult a clinician before use.
Supporting Ingredients
Turmeric
Turmeric
Origin: A culinary rhizome long used in Ayurveda. Modern trials employ curcumin-standardized extracts (often with bioavailability enhancers like piperine or novel dispersions).
How it works
Curcumin down-regulates NF-κB/COX-2 inflammatory signaling and activates Nrf2/HO-1 antioxidant defenses—mechanisms consistent with lower CRP/TNF-α/IL-6, improved joint function (WOMAC/KOOS), and immune support in human RCTs. (BPS Publications)
Top 5 Clinically Supported Benefits
1) Joint comfort & function (knee OA)
DB-RCTs and a 2022 meta-analysis of 29 RCTs (n=2,396) report significant pain and function improvements in arthritis; effects were comparable to NSAIDs with fewer adverse events. An 8-week DB-RCT in knee OA (n=101) using 500 mg BID curcumin improved KOOS pain, 6-min walk, and timed up-and-go vs placebo; pain-medication use fell (37% vs 13%). Study chips: Dose 500–1000 mg/day • Duration 8–12 wk • Endpoints WOMAC/KOOS, VAS, performance tests • Design DB-RCTs + meta-analysis. (Frontiers, MDPI)
2) Systemic inflammation markers ↓ (CRP, TNF-α, IL-6)
A DB-RCT in metabolic syndrome (n=117) using 1 g/day curcuminoids + piperine for 8 weeks reduced hs-CRP and oxidative stress; its embedded meta-analysis of RCTs confirmed CRP lowering. Multiple updated meta-analyses likewise show significant CRP/hs-CRP reductions. Study chips: Dose 500–1000 mg/day • Duration 8–12 wk • Endpoints CRP/hs-CRP, TNF-α, IL-6 • Design DB-RCT + meta-analyses. (Europe PMC, ScienceDirect)
3) Immune support (common cold symptoms)
In healthy adults (DB-RCT, n=99), 12 weeks of highly bioavailable curcumin (150 mg/day) shortened common-cold symptom duration and modulated immune/inflammatory readouts vs placebo. Study chips: Dose 150 mg/day (bioavailable) • Duration 12 wk • Endpoints symptom days/severity, immune markers • Design DB-RCT. (Taylor & Francis Online, Examine)
4) Exercise recovery & soreness (DOMS)
Across controlled human trials—including a double-blind cross-over and a DB-RCT with bioavailable curcumin—supplementation reduced muscle soreness and showed lower CK after eccentric exercise vs placebo. Study chips: Dose ~1.5–5 g/day (legacy) or bioavailable forms at lower mg • Duration peri-/post-exercise (2–7 days) • Endpoints DOMS ratings, CK • Design DB cross-over + DB-RCT. (SpringerLink, Europe PMC)
5) Quality & safety signals
Across arthritis RCTs, curcumin showed favorable tolerance and NSAID-like efficacy without increased adverse events, supporting use in joint-health stacks when monitored appropriately. Study chips: Dose 120–1500 mg/day • Duration 4–36 wk • Endpoints AE rates, discontinuations • Design Meta-analysis + RCTs. (Frontiers)
Summary
Human double-blind, placebo-controlled trials—plus large meta-analyses—indicate that standardized curcumin extracts can improve knee-OA pain/function, lower CRP and key cytokines, support immune resilience (shorter common-cold symptoms), and speed exercise recovery. Most effective protocols use bioavailability-enhanced curcumin at 150–1000 mg/day for 8–12 weeks, or peri-exercise for DOMS, with endpoints like WOMAC/KOOS, VAS, 6-min walk, CRP/hs-CRP, TNF-α/IL-6, symptom days, CK. To mirror trials, choose clearly standardized extract(s) with third-party COA, then use consistently for the studied window. (Frontiers, MDPI, Europe PMC, Taylor & Francis Online)
Why choose Organica to reach those outcomes
- Clinically aligned dosing (easy 150–1000 mg/day targeting; bioavailability-enhanced extract)
- Root-cause formulation: curcumin standardized; optional piperine or dispersion tech (per RCTs)
- Third-party COA (identity, curcuminoids by HPLC/UPLC, heavy metals, microbes, pesticides, solvents)
- cGMP small-batch, clean excipients; vegan capsules
References (MIT style, with links)
- Zeng, Liuting, Tiejun Yang, Kailin Yang, et al. “Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Frontiers in Immunology 13 (2022): 891822. https://doi.org/10.3389/fimmu.2022.891822. (Frontiers)
- Lopresti, Adrian L., Stephen J. Smith, Shavon Jackson-Michel, and Timothy Fairchild. “An Investigation into the Effects of a Curcumin Extract (Curcugen®) on Osteoarthritis Pain of the Knee: A Randomised, Double-Blind, Placebo-Controlled Study.” Nutrients 14, no. 1 (2022): 41. https://doi.org/10.3390/nu14010041. (MDPI)
- Panahi, Y., M. S. Hosseini, N. Khalili, E. Naimi, M. Majeed, and A. Sahebkar. “Antioxidant and Anti-inflammatory Effects of Curcuminoid-Piperine Combination in Subjects with Metabolic Syndrome: A Randomized Controlled Trial and an Updated Meta-analysis.” Clinical Nutrition 34, no. 6 (2015): 1101–1108. https://www.clinicalnutritionjournal.com/article/S0261-5614(15)00002-3/fulltext. (Clinical Nutrition Journal)
- Kuwabara, Y., A. Hirose, H. Lee, T. Kakinuma, A. Baba, and T. Takara. “Effects of Highly Bioavailable Curcumin Supplementation on Common Cold Symptoms and Immune and Inflammatory Functions in Healthy Japanese Subjects: A Randomized Controlled Study.” Journal of Dietary Supplements (2023). https://doi.org/10.1080/19390211.2023.2185723. (Taylor & Francis Online)
- Rowlands, D. S., R. Fazakerly, and J. Kellett. “Curcumin Supplementation Likely Attenuates Delayed Onset Muscle Soreness (DOMS).” European Journal of Applied Physiology 115 (2015): 1769–1777. https://doi.org/10.1007/s00421-015-3152-6. (SpringerLink)
Regulatory note: These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. If you use NSAIDs/anticoagulants, are pregnant/breastfeeding, or have gallbladder issues, consult a clinician before use.
Clinical Evidence on Turmeric
Turmeric
Turmeric
Origin: A culinary rhizome long used in Ayurveda. Modern trials employ curcumin-standardized extracts (often with bioavailability enhancers like piperine or novel dispersions).
How it works
Curcumin down-regulates NF-κB/COX-2 inflammatory signaling and activates Nrf2/HO-1 antioxidant defenses—mechanisms consistent with lower CRP/TNF-α/IL-6, improved joint function (WOMAC/KOOS), and immune support in human RCTs. (BPS Publications)
Top 5 Clinically Supported Benefits
1) Joint comfort & function (knee OA)
DB-RCTs and a 2022 meta-analysis of 29 RCTs (n=2,396) report significant pain and function improvements in arthritis; effects were comparable to NSAIDs with fewer adverse events. An 8-week DB-RCT in knee OA (n=101) using 500 mg BID curcumin improved KOOS pain, 6-min walk, and timed up-and-go vs placebo; pain-medication use fell (37% vs 13%). Study chips: Dose 500–1000 mg/day • Duration 8–12 wk • Endpoints WOMAC/KOOS, VAS, performance tests • Design DB-RCTs + meta-analysis. (Frontiers, MDPI)
2) Systemic inflammation markers ↓ (CRP, TNF-α, IL-6)
A DB-RCT in metabolic syndrome (n=117) using 1 g/day curcuminoids + piperine for 8 weeks reduced hs-CRP and oxidative stress; its embedded meta-analysis of RCTs confirmed CRP lowering. Multiple updated meta-analyses likewise show significant CRP/hs-CRP reductions. Study chips: Dose 500–1000 mg/day • Duration 8–12 wk • Endpoints CRP/hs-CRP, TNF-α, IL-6 • Design DB-RCT + meta-analyses. (Europe PMC, ScienceDirect)
3) Immune support (common cold symptoms)
In healthy adults (DB-RCT, n=99), 12 weeks of highly bioavailable curcumin (150 mg/day) shortened common-cold symptom duration and modulated immune/inflammatory readouts vs placebo. Study chips: Dose 150 mg/day (bioavailable) • Duration 12 wk • Endpoints symptom days/severity, immune markers • Design DB-RCT. (Taylor & Francis Online, Examine)
4) Exercise recovery & soreness (DOMS)
Across controlled human trials—including a double-blind cross-over and a DB-RCT with bioavailable curcumin—supplementation reduced muscle soreness and showed lower CK after eccentric exercise vs placebo. Study chips: Dose ~1.5–5 g/day (legacy) or bioavailable forms at lower mg • Duration peri-/post-exercise (2–7 days) • Endpoints DOMS ratings, CK • Design DB cross-over + DB-RCT. (SpringerLink, Europe PMC)
5) Quality & safety signals
Across arthritis RCTs, curcumin showed favorable tolerance and NSAID-like efficacy without increased adverse events, supporting use in joint-health stacks when monitored appropriately. Study chips: Dose 120–1500 mg/day • Duration 4–36 wk • Endpoints AE rates, discontinuations • Design Meta-analysis + RCTs. (Frontiers)
Summary
Human double-blind, placebo-controlled trials—plus large meta-analyses—indicate that standardized curcumin extracts can improve knee-OA pain/function, lower CRP and key cytokines, support immune resilience (shorter common-cold symptoms), and speed exercise recovery. Most effective protocols use bioavailability-enhanced curcumin at 150–1000 mg/day for 8–12 weeks, or peri-exercise for DOMS, with endpoints like WOMAC/KOOS, VAS, 6-min walk, CRP/hs-CRP, TNF-α/IL-6, symptom days, CK. To mirror trials, choose clearly standardized extract(s) with third-party COA, then use consistently for the studied window. (Frontiers, MDPI, Europe PMC, Taylor & Francis Online)
Why choose Organica to reach those outcomes
- Clinically aligned dosing (easy 150–1000 mg/day targeting; bioavailability-enhanced extract)
- Root-cause formulation: curcumin standardized; optional piperine or dispersion tech (per RCTs)
- Third-party COA (identity, curcuminoids by HPLC/UPLC, heavy metals, microbes, pesticides, solvents)
- cGMP small-batch, clean excipients; vegan capsules
References (MIT style, with links)
- Zeng, Liuting, Tiejun Yang, Kailin Yang, et al. “Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Frontiers in Immunology 13 (2022): 891822. https://doi.org/10.3389/fimmu.2022.891822. (Frontiers)
- Lopresti, Adrian L., Stephen J. Smith, Shavon Jackson-Michel, and Timothy Fairchild. “An Investigation into the Effects of a Curcumin Extract (Curcugen®) on Osteoarthritis Pain of the Knee: A Randomised, Double-Blind, Placebo-Controlled Study.” Nutrients 14, no. 1 (2022): 41. https://doi.org/10.3390/nu14010041. (MDPI)
- Panahi, Y., M. S. Hosseini, N. Khalili, E. Naimi, M. Majeed, and A. Sahebkar. “Antioxidant and Anti-inflammatory Effects of Curcuminoid-Piperine Combination in Subjects with Metabolic Syndrome: A Randomized Controlled Trial and an Updated Meta-analysis.” Clinical Nutrition 34, no. 6 (2015): 1101–1108. https://www.clinicalnutritionjournal.com/article/S0261-5614(15)00002-3/fulltext. (Clinical Nutrition Journal)
- Kuwabara, Y., A. Hirose, H. Lee, T. Kakinuma, A. Baba, and T. Takara. “Effects of Highly Bioavailable Curcumin Supplementation on Common Cold Symptoms and Immune and Inflammatory Functions in Healthy Japanese Subjects: A Randomized Controlled Study.” Journal of Dietary Supplements (2023). https://doi.org/10.1080/19390211.2023.2185723. (Taylor & Francis Online)
- Rowlands, D. S., R. Fazakerly, and J. Kellett. “Curcumin Supplementation Likely Attenuates Delayed Onset Muscle Soreness (DOMS).” European Journal of Applied Physiology 115 (2015): 1769–1777. https://doi.org/10.1007/s00421-015-3152-6. (SpringerLink)
Regulatory note: These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. If you use NSAIDs/anticoagulants, are pregnant/breastfeeding, or have gallbladder issues, consult a clinician before use.
Why Choose Our Tongkat Ali
Key Benefits
Rhizome-Only Extract – Concentrated actives from mature turmeric rhizome; excludes leaf or stems
Rhizome-Only Extract – Concentrated actives from mature turmeric rhizome; excludes leaf or stems
.svg)
Standardized Curcuminoids – Verified potent curcumin profile by third party independent testing
Standardized Curcuminoids – Verified potent curcumin profile by third party independent testing
Food-Grade Extraction – Clean CO₂ extration process preserving curcuminoids and aromatic oils
Food-Grade Extraction – Clean CO₂ extration process preserving curcuminoids and aromatic oils
Proven & Peer-Reviewed – Supported by real trials for testosterone, performance, and endurance
Proven & Peer-Reviewed – Supported by real trials for testosterone, performance, and endurance
Freshly Bottled – Sealed promptly after extraction for peak freshness, no stockpiled bulk
Freshly Bottled – Sealed promptly after extraction for peak freshness, no stockpiled bulk
Ethical Farming – Supports small family farms, not industrial or exploitative suppliers
Ethical Farming – Supports small family farms, not industrial or exploitative suppliers
Glass & Bamboo Packaging – Eco-friendly packaging that protects purity, no harmful plastics
Glass & Bamboo Packaging – Eco-friendly packaging that protects purity, no harmful plastics
QR Code Verified – Scan to see your batch’s lab report and source trail, no hidden supply chains
QR Code Verified – Scan to see your batch’s lab report and source trail, no hidden supply chains
No Fillers or Additives – 100% Turmeric root extract with nothing added, no fillers or flow agents
No Fillers or Additives – 100% Turmeric root extract with nothing added, no fillers or flow agents
Vegan & Allergen-Free – No animal products, dairy, soy, gluten, or common allergens
Vegan & Allergen-Free – No animal products, dairy, soy, gluten, or common allergens
Recovery Relief
Liam Foster
Mobility Ease
Maya Patel
Joint Comfort
Diego Ramirez
Inflammation Support
Hannah Greene
.svg)
.svg)
.svg)
Reviews
.svg)
Quentin V.
.svg)
.svg)
.svg)
Cooking Win
Turmeric in rice and soups is a flavor win. Makes dinner look pretty too.
Marisol G.
Comfort After Lifts
After heavy lifts I notice I move more freely the next day. Worth keeping.
Giselle T.
Warmth Without Heartburn
Warm, gentle feel with zero heartburn. That’s been hard to find for me.
Jonah U.
Not a Miracle, Still Useful
Not a cure‑all, just a helpful piece of the routine I can stick with.
Write Review
.svg)
Turmeric - Frequently Asked Questions
Organica’s Turmeric capsules contain 500 mg of pure, standardized curcumin extract (≥95% total curcuminoids) per capsule, formulated to ensure consistent, high-strength dosing.
Curcumin modulates immune activity by downregulating pro-inflammatory cytokines (TNF-α, IL-1β) and inhibiting NF-κB signaling. In clinical trials, 1 g/day for 8–12 weeks reduced C-reactive protein by up to 2.20 mg/L, reflecting a more balanced immune response.
In an 8-week RCT of rheumatoid arthritis patients, 500 mg curcumin twice daily outperformed diclofenac in improving Disease Activity Score-28 and ACR criteria by inhibiting COX-2 and other inflammatory enzymes, leading to reduced joint pain and swelling.
Take two 500 mg capsules daily with meals (total 1,000 mg curcumin) to maintain therapeutic blood levels of curcuminoids and sustain continuous anti-inflammatory and antioxidant activity.
Most users report increased total antioxidant capacity and elevated superoxide dismutase activity within 4–8 weeks of daily supplementation at 1,000–1,500 mg, alongside significant reductions in malondialdehyde levels, indicating lower oxidative stress.
Turmeric is generally well-tolerated at doses up to 2,000 mg/day. Mild gastrointestinal discomfort can occur if taken without food and curcumin may affect blood clotting, so consult a healthcare provider before use if you take anticoagulant or antiplatelet medications.
